Sartorius, DE0006292006

Sartorius stock holds near TecDAX levels as investors weigh latest guidance

Published on 09/02/2026 at 21:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sartorius stock is trading close to recent highs on Xetra as investors digest the latest half-year figures and guidance for 2026, while the TecDAX weighting underlines its role as a core German life sciences name.

Flatlay mit Aktienzertifikat, ISIN-Karte, Pipette, Filter und Zellkulturbeutel — Sartorius AG (Vz.) DE0006292006 zeigt als Flatlay ein Aktienzertifikat, eine ISIN-Karte, Pipette, Filter und Zellkulturbeutel, Illustration mit AI erstellt.

Sartorius (ISIN DE0006292006) stock recently traded around 194.80 EUR on Xetra as of September 2, 2026, after a prior close near 193.80 EUR, leaving the share price within a 52-week range of 154.20 EUR to 208.00 EUR according to market data from Yahoo Finance and other portals.

Stock stabilizes after recent recovery

According to market data compiled by Yahoo Finance, Sartorius stock closed at 194.80 EUR on Xetra on September 2, 2026, down 1.42% from the previous close, with an intraday quote around 193.80 EUR earlier in the session.

The same data show a 52-week range between 154.20 EUR and 208.00 EUR, placing the latest closing price less than 6.4% below the 52-week high and more than 26.3% above the 52-week low, which underlines the stock's recovery from earlier lows within the last year.

TecDAX weighting highlights market relevance

An overview of the iShares TecDAX UCITS ETF from Finanzen shows that Sartorius AG participating preferred shares carry a weighting of 4.58% in the TecDAX as of March 30, 2026, underscoring the company's importance in Germany's technology and life sciences segment.

The same TecDAX overview indicates that this weighting corresponds to a market capitalization figure of about 14,335,933,736 EUR for Sartorius AG participating preferred shares as of the latest update, which illustrates the company's significant size within the index and supports its status as a core holding for many German technology-focused investors.

Go deeper

More news and data on Sartorius

Further articles, ad hoc announcements and financial data on Sartorius can be found in the topic overview for this ISIN.

All articles on Sartorius Investor Relations

Bioprocess solutions as key driver

Sartorius focuses on bioprocess solutions for biopharmaceutical manufacturing, supplying filtration, fermentation and analytical technologies that enable customers to produce biologic medicines at scale.

Sartorius stock price snapshot

Based on the Xetra data from Yahoo Finance as of September 2, 2026, Sartorius stock closed at 194.80 EUR on that date, with the price sitting in the upper half of the 52-week band between 154.20 EUR and 208.00 EUR and reflecting a modest daily decline of 1.42%.